Cargando…
Preclinical studies on the toxicology, pharmacokinetics and safety of K1-70(TM) a human monoclonal autoantibody to the TSH receptor with TSH antagonist activity
BACKGROUND: The human monoclonal autoantibody K1-70™ binds to the TSH receptor (TSHR) with high affinity and blocks TSHR cyclic AMP stimulation by TSH and thyroid stimulating autoantibodies. METHODS: The preclinical toxicology assessment following weekly intravenous (IV) or intramuscular (IM) admini...
Autores principales: | Furmaniak, Jadwiga, Sanders, Jane, Clark, Jill, Wilmot, Jane, Sanders, Paul, Li, Yang, Rees Smith, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065368/ https://www.ncbi.nlm.nih.gov/pubmed/32257067 http://dx.doi.org/10.1186/s13317-019-0121-9 |
Ejemplares similares
-
TSH receptor specific monoclonal autoantibody K1‐70(TM) targeting of the TSH receptor in subjects with Graves' disease and Graves' orbitopathy—Results from a phase I clinical trial
por: Furmaniak, Jadwiga, et al.
Publicado: (2022) -
Practical applications of studies on the TSH receptor and TSH receptor autoantibodies
por: Furmaniak, J., et al.
Publicado: (2020) -
Blocking type TSH receptor antibodies
por: Furmaniak, Jadwiga, et al.
Publicado: (2012) -
Structure and activation of the TSH receptor transmembrane domain
por: Núñez Miguel, Ricardo, et al.
Publicado: (2016) -
Structure of full-length TSH receptor in complex with antibody K1-70™
por: Núñez Miguel, Ricardo, et al.
Publicado: (2022)